Want to see IN:MOREPENLAB full AI Analyst Report?
ETFs with Morepen Laboratories Limited (MOREPENLAB) Exposure
The following ETFs maintain exposure to Morepen Laboratories Limited (IN:MOREPENLAB). ETF holdings data are updated periodically, based on the latest holdings the ETFs report, and are subject to change. To see a complete breakdown of any of the ETFs included in the table below, including asset class, AUM, and country allocations, click on the ticker symbol.
12 ETFs Hold Morepen Laboratories Limited (MOREPENLAB)
| Symbol | ETF Name | AUM | Expense Ratio | % Weight in ETF | Market Value | % Weight in MOREPENLAB |
|---|---|---|---|---|---|---|
| EWX | SPDR S&P Emerging Markets Small Cap ETF | $624.66M | 0.65% | 0.04% | $265.34K | 0.04% |
| AVEE | Avantis Emerging Markets Small Cap Equity ETF | $140.69M | 0.42% | 0.03% | $35.26K | <0.01% |
| DEXC | Dimensional Emerging Markets ex China Core Equity ETF | $276.59M | 0.43% | 0.02% | $64.33K | <0.01% |
| DFEV | Dimensional Emerging Markets Value ETF | $2.18B | 0.43% | 0.02% | $373.61K | 0.05% |
| SPEM | SPDR Portfolio Emerging Markets ETF | $16.38B | 0.07% | <0.01% | $1.26M | 0.18% |
| CAEM | Avantis CIBC Emerging Markets Equity ETF Trust Unit | $154.94M | ― | <0.01% | $10.46K | <0.01% |
| DFEM | Dimensional Emerging Markets Core Equity 2 ETF | $9.08B | 0.39% | <0.01% | $536.63K | 0.08% |
| DFAE | Dimensional Emerging Core Equity Market ETF | $9.42B | 0.29% | <0.01% | $499.60K | 0.07% |
| AVEM | Avantis Emerging Markets Equity ETF | $27.48B | 0.33% | <0.01% | $1.38M | 0.20% |
| AVXC | Avantis Emerging Markets ex-China Equity ETF | $440.92M | 0.33% | <0.01% | $22.07K | <0.01% |
| AVEG | Avantis Emerging Markets Equity Ucits ETF AccumUSD | $312.59M | 0.38% | <0.01% | $15.10K | <0.01% |
| DFAX | Dimensional World ex U.S. Core Equity 2 ETF | $12.19B | 0.28% | <0.01% | $420.54K | 0.06% |
| Symbol | % Weight in ETF | ETF Name | AUM | Expense Ratio | Market Value | % Weight in MOREPENLAB |
|---|---|---|---|---|---|---|
| EWX | 0.04% | SPDR S&P Emerging Markets Small Cap ETF | $624.66M | 0.65% | $265.34K | 0.04% |
| AVEE | 0.03% | Avantis Emerging Markets Small Cap Equity ETF | $140.69M | 0.42% | $35.26K | <0.01% |
| DEXC | 0.02% | Dimensional Emerging Markets ex China Core Equity ETF | $276.59M | 0.43% | $64.33K | <0.01% |
| DFEV | 0.02% | Dimensional Emerging Markets Value ETF | $2.18B | 0.43% | $373.61K | 0.05% |
| SPEM | <0.01% | SPDR Portfolio Emerging Markets ETF | $16.38B | 0.07% | $1.26M | 0.18% |
| CAEM | <0.01% | Avantis CIBC Emerging Markets Equity ETF Trust Unit | $154.94M | ― | $10.46K | <0.01% |
| DFEM | <0.01% | Dimensional Emerging Markets Core Equity 2 ETF | $9.08B | 0.39% | $536.63K | 0.08% |
| DFAE | <0.01% | Dimensional Emerging Core Equity Market ETF | $9.42B | 0.29% | $499.60K | 0.07% |
| AVEM | <0.01% | Avantis Emerging Markets Equity ETF | $27.48B | 0.33% | $1.38M | 0.20% |
| AVXC | <0.01% | Avantis Emerging Markets ex-China Equity ETF | $440.92M | 0.33% | $22.07K | <0.01% |
| AVEG | <0.01% | Avantis Emerging Markets Equity Ucits ETF AccumUSD | $312.59M | 0.38% | $15.10K | <0.01% |
| DFAX | <0.01% | Dimensional World ex U.S. Core Equity 2 ETF | $12.19B | 0.28% | $420.54K | 0.06% |

Popular ETF Comparisons
MOREPENLAB ETF Exposure FAQ
What ETFs hold Morepen Laboratories Limited stock?
Morepen Laboratories Limited (IN:MOREPENLAB) is currently held by 12 ETFs in TipRanks’ ETF exposure database. The ETF(s) with exposure to IN:MOREPENLAB include Avantis (AVEM), State Street (SPEM) and Dimensional (DFEM).
Which ETF has the largest exposure to IN:MOREPENLAB?
The ETF with the largest exposure to IN:MOREPENLAB is Avantis (AVEM), with approximately INR 1.38M in market value exposure.
How much IN:MOREPENLAB stock is held by ETFs?
ETFs currently hold approximately INR 4.45M worth of Morepen Laboratories Limited (IN:MOREPENLAB) stock, based on TipRanks’ ETF exposure data.
How often is ETF exposure data updated?
ETF exposure data is updated periodically based on the latest available ETF holdings and reporting data. Actual ETF positions may change between reporting periods.